NDC-026

N/A

Report date: 2026/01/14 10:59:49

Base Information

Drug NameNDC-026
Drug Alias NameFixed-dosed combination of L-citrulline + allopurinolL-citrulline/AllopurinolNDC-026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donorsXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes L-CitrullineAllopurinol
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDr. Noah Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesDr. Noah Biotech Inc
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A